Recommendation RRoutine follow up and imaging of patients with melanoma should be offered in line with the NHSScotland Cutaneous Melanoma National Follow-Up guideline.

Recommendation RPatients should have a holistic needs assessment at regular intervals during follow up to support their physical and mental wellbeing.

NHSScotland Cutaneous Melanoma National Follow Up Guideline surveillance schedule

Stage

Risk

Clinical review

Imaging

IA Low

Dermatology/surgical clinic

Every 3–6 months for 12 months
 
IB-IIA Low

Dermatology/surgical clinic

Every 3–4 months for years 1–3

Every 6 months for years 4–5
 

IIIA with <1mm SLN deposit

Also earlier stages where SLNB considered appropriate but unable to complete.

Low

Dermatology/surgical clinic

Every 3–4 months for years 1–3

Every 6 months for years 4–5

Ultrasound of nodal basin (if available)

Every 6 months for years 1–3

Annually for years 4–5

(if not having CLND and not having cross-sectional imaging follow up)

IIB, IIC, IIIA (with >1mm deposit), IIIB

 

Also earlier stages with high-risk features (eg primary mitotic rate)

*Patients on adjuvant treatment see below
Moderate

Dermatology/surgical clinic

Every 3–4 months for years 1–3

Every 6 months for years 4–5

Annually for years 6–10

Baseline: CE-CT HCAP

Years 1–3: 6-monthly CE-CT HCAP

Years 4–5: Annual CE-CT HCAP (include neck in all CTs if primary drainage is into the head or neck)

IIIC

*Patients on adjuvant treatment see below
High

Oncology and dermatology/surgical clinics

Every 3 months for years 1–2

Every 6 months for years 3–5

Annually for years 6–10

Baseline: CE-CT HCAP

Years 1–3: 6-monthly CT HCAP

Years 4–5: Annual CE-CT HCAP

(include neck in all CTs if primary drainage is into the head or neck)

IIID or fully resected IV

*Patients on adjuvant treatment see below
Very high

Oncology and dermatology/surgical clinics

Every 3 months for years 1–2

Every 6 months for years 3–5

Annually for years 6–10

Baseline: CE-CT HCAP

Year 1: 3-monthly CE-CT HCAP

Years 2–3: 3–6 monthly CE-CT HCAP

Years 4–5: Annual CE-CT HCAP

(include neck in all CTs if primary drainage is into the head or neck)

Note: brain imaging 6-monthly in years 1–3, unless resected brain metastases then MRI 3-monthly in year 1 and 3–6 monthly in years 2–3, and annual in years 4–5
Unresectable III/IV Very high

Oncology clinic may need to be tailored to individual.

Completed SACT:

Every 3 months for years 1–3 Every 6 months for years 4–5 Annually for years 6–10

Baseline: CE-CT HCAP

On SACT treatment:

Years 1–2: CE-CT HCAP 3-monthly (brain imaging 6-monthly unless brain metastases)

Years 3 and beyond: CE-CT HCAP 6-monthly

 

End of treatment: If residual disease seen on  CT or if disease only seen on PET** then PET followed by:

Years 1–3: CT CAP months 3, 6, 12, 18, 24, 30, 36. Include 6-monthly CE-CT H

Years 4–5: Annual CE-CT CAP include CT H at year 5

(include neck to all CTs if primary or metastases in the head or neck. If had SRS or brain surgery image with MRI to head)

CE-CT HCAP – contrast-enhanced computed tomography of the head, chest, abdomen and pelvis;

CLND - completion lymphadenectomy; SACT – systemic anticancer therapy; SRS - stereostatic radiosurgery

*For patients on adjuvant systemic therapy, surveillance body scans are recommended every 3–4 months and head scans every 6 months whilst on treatment, and then as above after treatment, based on their stage.

** All PET-CTs should be considered on a patient-by-patient basis, ideally with MDT discussion.